ubmslateCN-logo-ubm

CN Mobile Logo

Topics:

Head & Neck Cancer

ASCO 2016 Genitourinary Cancers Symposium

Cancer Network presents exclusive coverage from the American Society of Clinical Oncology (ASCO) 2016 Genitourinary Cancers Symposium, held January 7–9 in San Francisco. We’ll bring you reports as we cover the latest research, trials, scientific advances, and controversies that are changing the way genitourinary cancers are managed and treated.

Head & Neck Cancer

The combination of radiation therapy plus cetuximab had higher rates of acute toxicity among patients with locally advanced squamous cell carcinoma of the head and neck compared with radiation therapy plus cisplatin.

Compared to the general population, the rate of suicide is three times more frequent among head and neck cancer patients, according to a retrospective study.

This article reviews the pathology and current evidence on systemic therapies for the management of advanced salivary gland cancers that are not amenable to local therapy.

The diversity and complexity, combined with the rarity of salivary gland malignancies, lead to definite and distinct challenges in their study, and consequently in advancing treatment options for affected patients.

Undergoing primary surgery may be the best treatment option for patients with advanced oropharyngeal and hypopharyngeal cancers.

Pretreatment depression was linked with poorer nutritional and survival outcomes among newly diagnosed patients with head and neck squamous cell carcinoma.

By introducing a patient-centric navigation system, researchers were able to provide treatment recommendations to the majority of patients with head and neck cancer within a 2-week period.

Pages

Subscribe to Head & Neck Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.